[Serum thymic activity in patients with cancer of the stomach and esophagus and its changes after the combined treatment including immunotherapy].
Grinevich
Iu A
IuA
Kamenets
L Ia
LIa
Selezneva
T N
TN
Ganul
V L
VL
Okulov
L V
LV
D000276:Adjuvants, Immunologic; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D011182:Postoperative Care; D013274:Stomach Neoplasms / Q000276:immunology* / Q000628:therapy; D013946:Thymopoietins / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000097:blood* / Q000172:deficiency
D000276:Adjuvants, Immunologic; D013946:Thymopoietins; D013949:Thymus Extracts; D013951:Thymus Hormones; C031407:thymostimulin; C032841:thymopoietin III
Timicheskaia syvorotochnaia aktivnost' u bol'nykh rakom zheludka i pishchevoda i ee izmenenie pod vliianiem kombinirovannogo lecheniia s vkliucheniem immunoterapii.